Pricing Log in Create free account

Lexaria Bioscience Corp. (LEXX) vs NeuroSense Therapeutics Ltd. (NRSN)

Lexaria Bioscience Corp. and NeuroSense Therapeutics Ltd. are both Biotechnology companies. Lexaria Bioscience Corp. and NeuroSense Therapeutics Ltd. are of similar size ($6.3M and $6.0M). Across the 8 metrics below, NeuroSense Therapeutics Ltd. leads on 5 and Lexaria Bioscience Corp. on 3.

Valuation

Metric LEXX NRSN Biotechnology median
P/E n/m n/m 8.50
P/S 8.91 n/m 9.71
P/B 1.11 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.36 n/m 9.21
Earnings yield (174.57%) (406.90%) (33.15%)
Free cash flow yield (155.80%) (444.35%) (25.50%)

Profitability

Metric LEXX NRSN Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (162.60%) 0.00% (56.36%)
Return on assets (134.20%) 0.00% (48.04%)
Return on invested capital (662.56%) 0.00% 0.00%

Growth

Metric LEXX NRSN Biotechnology median
Revenue growth (TTM) 9.08% — 6.02%
EPS growth (last fiscal year) (40.43%) 18.52% 30.26%
Revenue growth, 5-year CAGR 17.53% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LEXX NRSN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.60 0.28 4.72
Net debt to EBITDA 0.17 0.01 0.96

Dividend

Metric LEXX NRSN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LEXX NRSN Biotechnology median
Market cap 6.30m 6.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack